GGrantIndex
Sort

326,823 grants matching clinical trial

Improved Diagnosis and Treatment of Cushing's Disease

$2,068,980
Prashant Chittiboina · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

Molecular Diagnostics Core Laboratory

$2,068,937
Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

Antecedent Biomarkers For AD: The Adult Children Study

$2,068,818
John Morris · Washington University · P01 · FY2020 · AG

1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)

$2,068,764
Joseph Eric Levitt · Stanford University · UH3 · FY2022 · HL

Heart Failure Clinical Research Network Coordinating Center

$2,068,753
Kevin J Anstrom · Duke University · U10 · FY2016 · HL

NIDA Clinical Trials Network: New York Node

$2,068,510
John P Rotrosen · New York University School Of Medicine · UG1 · FY2022 · DA

Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox

$2,068,496
Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2009 · AI

Maternal Fetal Medicine Network: Data Coordinating Cent*

$2,068,237
Elizabeth A Thom · George Washington University · U01 · FY2008 · HD

CORAL: Clinical Coordinating Center

$2,068,167
University Of Toledo Health Sci Campus · U01 · FY2004 · HL

Central Nervous System Drug Delivery Techniques

$2,068,109
Russell Lonser · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS

DETECT-AD: Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's Disease

$2,068,051
Jeffrey A Kaye · Oregon Health & Science University · R56 · FY2022 · AG

Anatomic Pathology Residency Program

$2,067,992
Frederic Barr · Division Of Basic Sciences - Nci · ZIE · FY2023 · CA

REGULATORY MANAGEMENT CENTER

$2,067,893
Charity-Anne Schuller · Ppd Development Lp · N01 · FY2017 · AI

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs

$2,067,796
Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA

RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD

$2,067,659
Scott T Weiss · Brigham And Women'S Hospital · R01 · FY2014 · HL

Alzheimer's Disease and Animal Models

$2,067,655
Donald L Price · Johns Hopkins University · P50 · FY2009 · AG

1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)

$2,067,564
Valerie Lynn Baker · Johns Hopkins University · R01 · FY2020 · HD

Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit

$2,067,523
Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2018 · AI

Antecedent Biomarkers For AD: The Adult Children Study

$2,067,511
John Morris · Washington University · P01 · FY2017 · AG

SPORE in Brain Cancer

$2,067,370
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

Statistical Methods for Cancer Clinical Trials

$2,067,189
Michael R Kosorok · Univ Of North Carolina Chapel Hill · P01 · FY2014 · CA

Targeted Bone Regeneration via Activation of Resident Stem Cells

$2,066,904
Tracey Rogers · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

Statistical Methods for Cancer Clinical Trials

$2,066,666
Michael R Kosorok · Univ Of North Carolina Chapel Hill · P01 · FY2017 · CA

Molecularly Targeted Radiosensitization of Locally Advanced Cancers

$2,066,150
Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2023 · CA

Biodefense/Emerging Infection Vaccine Studies

$2,065,989
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI